DeciBio Ventures flags pharma services sector push into AI — enabled clinical development in Q3 2026 roundup
DeciBio Ventures’ Q3 2026 pharma services round-up flagged accelerating AI adoption across clinical development platforms. ICON entered a multi-year collaboration with Anthropic to embed Claude into Orbis for trial operations, including site selection. Samsung Biologics launched an all-cash tender offer of $1.8 billion